WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Breast Cancer Endpoints - Master Primary m5.3, Primary endpoints has_outcome Curative intent, Overall Survival (OS) starts_concurrent_with Date of Randomization, Neoadjuvant setting endpoints has_component Overall Survival (OS), FDA Criteria for Efficacy endpoints for Breast Cancer treatment has_pertinent_information Tumor Biopsy, Main concept groups (e.g. Primary endpoints) are denoted by Larger bold font with thicker outline, Non-measurable lesions has_subtype Cystic lesion, Number of nodes examined has_status Negative, Positive has_follow_up No axillary dissection, Negative indicates pCR positive, Progression free survival (PFS) ends_concurrent_with Date of progression, Adjuvant setting endpoints has_component Disease free survival (DFS), Axillary lymph nodes have_dissection_options Axillary dissection, FDA Criteria for Efficacy endpoints for Breast Cancer treatment has_pertinent_information Cancer stage, Tumor assessment is_derived_from RECIST v1.1 criteria, Target lesion has_component Quantitative assessment, Neoadjuvant setting endpoints has_component Pathologic complete response (pCR), Demographics/Medical history has_components >Age >Ethnicity >Pregnancy status >BRCA1/2 mutation >Gene expression >Co-morbidities, Positive has_subset Number of nodes positive, Pathologic complete response (pCR) is_evaluated_using Breast specimen, Concepts (e.g. CRF:pCR:Surgical margins are denoted by solid round-edged rectangle